My Quote Request
No products added yet
6505-01-156-2044
20 Products
NDC52544-0496-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
NDC52544-0496-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
MFG
WATSON LABS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.008 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.13 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE CAPSULES USP 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-2712-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
NDC00781-2712-01
LOXAPINE CAPSULES,USP
NSN, MFG P/N
6505011562044
NSN
6505-01-156-2044
MFG
SANDOZ INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.10 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.008 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.13 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LOXAPINE CAPSULES USP 25MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NAVANE
THIOTHIXENE CAPSULES,USP
NSN, MFG P/N
6505011562045
NSN
6505-01-156-2045
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS THIOTHIXENE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIOTHIXENE CAPSULES USP 20MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NAVANE CAPSULES
THIOTHIXENE CAPSULES,USP
NSN, MFG P/N
6505011562045
NSN
6505-01-156-2045
NAVANE CAPSULES
THIOTHIXENE CAPSULES,USP
NSN, MFG P/N
6505011562045
NSN
6505-01-156-2045
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS THIOTHIXENE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIOTHIXENE CAPSULES USP 20MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00049-5770-66
THIOTHIXENE CAPSULES,USP
NSN, MFG P/N
6505011562045
NSN
6505-01-156-2045
NDC00049-5770-66
THIOTHIXENE CAPSULES,USP
NSN, MFG P/N
6505011562045
NSN
6505-01-156-2045
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS THIOTHIXENE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THIOTHIXENE CAPSULES USP 20MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00026-0685-20
ALBUMIN HUMAN,USP
NSN, MFG P/N
6505011562047
NSN
6505-01-156-2047
MFG
TALECRIS BIOTHERAPEUTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALBUMIN HUMAN USP 5%/ML VIAL
SPECIAL FEATURES: PEDIATRIC SIZE;W/O ADMINISTRATION SET;50 ML
Related Searches:
NDC00161-0685-20
ALBUMIN HUMAN,USP
NSN, MFG P/N
6505011562047
NSN
6505-01-156-2047
MFG
CUTTER LABORATORIES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALBUMIN HUMAN USP 5%/ML VIAL
SPECIAL FEATURES: PEDIATRIC SIZE;W/O ADMINISTRATION SET;50 ML
Related Searches:
CYCLOGYL
CYCLOPENTOLATE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011562083
NSN
6505-01-156-2083
CYCLOGYL
CYCLOPENTOLATE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011562083
NSN
6505-01-156-2083
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V CYCLOPENTOLATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHCLOPENTOLATE HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: MULTIPLE DOSE PLASTIC SQUEEZE BT
Related Searches:
NDC00065-0397-15
CYCLOPENTOLATE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011562083
NSN
6505-01-156-2083
NDC00065-0397-15
CYCLOPENTOLATE HYDROCHLORIDE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505011562083
NSN
6505-01-156-2083
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 PERCENTAGE, W/V CYCLOPENTOLATE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHCLOPENTOLATE HYDROCHLORIDE OPHTHALMIC SOLUTION USP 15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
SPECIAL FEATURES: MULTIPLE DOSE PLASTIC SQUEEZE BT
Related Searches:
NDC00009-3773-01
ESTROPIPATE TABLETS,USP
NSN, MFG P/N
6505011562089
NSN
6505-01-156-2089
NDC00009-3773-01
ESTROPIPATE TABLETS,USP
NSN, MFG P/N
6505011562089
NSN
6505-01-156-2089
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 MILLIGRAMS ESTROPIPATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTROPIPATE TABLETS USP 1.25MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
OGEN
ESTROPIPATE TABLETS,USP
NSN, MFG P/N
6505011562089
NSN
6505-01-156-2089
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.250 MILLIGRAMS ESTROPIPATE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTROPIPATE TABLETS USP 1.25MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00140-0007-01
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011562119
NSN
6505-01-156-2119
NDC00140-0007-01
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011562119
NSN
6505-01-156-2119
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES 100S
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HAFFMAN-LA ROCHE INC
Related Searches:
NDC00026-0636-01
GLOBULIN,HEPATITIS B IMMUNE,USP
NSN, MFG P/N
6505011562141
NSN
6505-01-156-2141
NDC00026-0636-01
GLOBULIN,HEPATITIS B IMMUNE,USP
NSN, MFG P/N
6505011562141
NSN
6505-01-156-2141
MFG
TALECRIS BIOTHERAPEUTICS INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN, HEPITITIS B IMMUNE, USP
IMMEDIATE CONTAINER TYPE: VIAL
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 1 ML
SPECIAL FEATURES: FOR INTRAMUSCULAR USE ONLY
Related Searches:
ELDOQUIN FORTE
HYDROQUINONE CREAM,USP
NSN, MFG P/N
6505011562146
NSN
6505-01-156-2146
ELDOQUIN FORTE
HYDROQUINONE CREAM,USP
NSN, MFG P/N
6505011562146
NSN
6505-01-156-2146
MFG
ELDER PHARMACEUTICALS INC
Description
ACTIVE INGREDIENT AND STRENGTH: 4.000 HYDROQUINONE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROQUINONE CREAM USP 4% 1OZ OR 30GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES OR 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
Related Searches:
NDC00163-0394-31
HYDROQUINONE CREAM,USP
NSN, MFG P/N
6505011562146
NSN
6505-01-156-2146
NDC00163-0394-31
HYDROQUINONE CREAM,USP
NSN, MFG P/N
6505011562146
NSN
6505-01-156-2146
MFG
ELDER PHARMACEUTICALS INC
Description
ACTIVE INGREDIENT AND STRENGTH: 4.000 HYDROQUINONE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROQUINONE CREAM USP 4% 1OZ OR 30GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES OR 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
Related Searches:
NDC00187-0394-31
HYDROQUINONE CREAM,USP
NSN, MFG P/N
6505011562146
NSN
6505-01-156-2146
NDC00187-0394-31
HYDROQUINONE CREAM,USP
NSN, MFG P/N
6505011562146
NSN
6505-01-156-2146
MFG
ICN PHARMACEUTICALS INC
Description
ACTIVE INGREDIENT AND STRENGTH: 4.000 HYDROQUINONE PERCENTAGE, W/W
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROQUINONE CREAM USP 4% 1OZ OR 30GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 OUNCES OR 30.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
Related Searches:
DEPO-MEDROL
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505011562174
NSN
6505-01-156-2174
DEPO-MEDROL
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505011562174
NSN
6505-01-156-2174
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS METHYLPREDNISOLONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE ACETATE INJECTABLE SUSP USP 80MG 1ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
DEPO-MEDROL SUSPENSION
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505011562174
NSN
6505-01-156-2174
DEPO-MEDROL SUSPENSION
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505011562174
NSN
6505-01-156-2174
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS METHYLPREDNISOLONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE ACETATE INJECTABLE SUSP USP 80MG 1ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00009-0306-01
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505011562174
NSN
6505-01-156-2174
NDC00009-0306-01
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505011562174
NSN
6505-01-156-2174
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS METHYLPREDNISOLONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE ACETATE INJECTABLE SUSP USP 80MG 1ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00009-3475-01
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505011562174
NSN
6505-01-156-2174
NDC00009-3475-01
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION,USP
NSN, MFG P/N
6505011562174
NSN
6505-01-156-2174
MFG
PFIZER INC. DBA PFIZER
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS METHYLPREDNISOLONE ACETATE ACTIVE INGREDIENT
ADMINISTRATION: INTRAMUSCULAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLPREDNISOLONE ACETATE INJECTABLE SUSP USP 80MG 1ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
